卓珈控股(01827.HK)預計年度淨虧約1200萬港元-1300萬港元
格隆匯6月9日丨卓珈控股(01827.HK)公吿,截至2021年3月31日止年度的集團未經審核綜合管理賬目以及董事會目前可得資料的初步評估,集團預計將錄得虧損淨額約1200萬港元至1300萬港元,去年同期則錄得純利約1360萬港元。
預期虧損主要由於收益較去年同期減少超過25%。新冠肺炎疫情為集團業務帶來了前所未有的干擾。由於香港政府實施的社交距離措施及於部分時間強制關閉香港的所有美容院,進一步導致集團無法開展業務。該等因素在年度對集團的財務業績造成不利影響。
Follow us
Find us on
Facebook,
Twitter ,
Instagram, and
YouTube or frequent updates on all things investing.Have a financial topic you would like to discuss? Head over to the
uSMART Community to share your thoughts and insights about the market! Click the picture below to download and explore uSMART app!

Disclaimers
uSmart Securities Limited (“uSmart”) is based on its internal research and public third party information in preparation of this article. Although uSmart uses its best endeavours to ensure the content of this article is accurate, uSmart does not guarantee the accuracy, timeliness or completeness of the information of this article and is not responsible for any views/opinions/comments in this article. Opinions, forecasts and estimations reflect uSmart’s assessment as of the date of this article and are subject to change. uSmart has no obligation to notify you or anyone of any such changes. You must make independent analysis and judgment on any matters involved in this article. uSmart and any directors, officers, employees or agents of uSmart will not be liable for any loss or damage suffered by any person in reliance on any representation or omission in the content of this article. The content of the article is for reference only and does not constitute any offer, solicitation, recommendation, opinion or guarantee of any securities, virtual assets, financial products or instruments. Regulatory authorities may restrict the trading of virtual asset-related ETFs to only investors who meet specified requirements. Any calculations or images in the article are for illustrative purposes only.
Investment involves risks and the value and income from securities may rise or fall. Past performance is not indicative of future performance. Please carefully consider your personal risk tolerance, and consult independent professional advice if necessary.